Peripheral PD1-positive CD4 T-Lymphocyte Count Can Predict Progression-free Survival in Patients With Non-small Cell Lung Cancer Receiving Immune Checkpoint Inhibitor

Minehiko Inomata, Tomonobu Kado, Seisuke Okazawa, +11

Anticancer Research

SIRT1 and FOXO1 mRNA expression in PBMC correlates to physical activity in COPD patients

Chihiro Taka, Ryuji Hayashi, Kazuki Shimokawa, +7

International Journal of COPD

Elevated levels of plasma lactate dehydrogenase is an unfavorable prognostic factor in patients with epidermal growth factor receptor mutation-positive non-small cell lung cancer, receiving treatment with gefitinib or erlotinib

Minehiko Inomata, Ryuji Hayashi, Hiroaki Tanaka, +11

Molecular and Clinical Oncology

Lactate Dehydrogenase and Body Mass Index are Prognostic Factors in Patients with Recurrent Small Cell Lung Cancer Receiving Amrubicin

Minehiko Inomata, Ryuji Hayashi, Kotaro Tokui, +9

Tumori Journal

Clinical Parameters for Predicting the Survival in Patients with Squamous and Non-squamous-cell NSCLC Receiving PD-1 Inhibitor Therapy

Minehiko Inomata, Takahiro Hirai, Zenta Seto, +10

Pathology & Oncology Research

OncologyNovel TherapyPharmacologyImmune Checkpoint InhibitorPharmacotherapy +3

Peripheral CD4 memory T cells predict the efficacy of immune checkpoint inhibitor therapy in patients with non-small cell lung cancer

Minehiko Inomata, Masahiro Matsumoto, Naoki Takata, +12

Scientific Reports

Outcome and prognostic factors in patients with small cell lung cancer who receive third-line chemotherapy.

Minehiko Inomata, Ryuji Hayashi, Kotaro Tokui, +10

PubMed

Association of serum adiponectin with asthma and pulmonary function in the Japanese population

Yasuko Hayashikawa, Minoru Iwata, Minehiko Inomata, +12

Endocrine Journal

AsthmaMetabolic SyndromeSerum AdiponectinTotal Adiponectin LevelInflammatory Lung Disease +10

Association of Tumor PD-L1 Expression with the T790M Mutation and Progression-Free Survival in Patients with EGFR-Mutant Non-Small Cell Lung Cancer Receiving EGFR-TKI Therapy

Minehiko Inomata, Kenji Azechi, Naoki Takata, +10

Diagnostics

Outcome and Prognostic Factors in Patients with Small Cell Lung Cancer who Receive Third-line Chemotherapy

Minehiko Inomata, Ryuji Hayashi, Kotaro Tokui, +10

Tumori Journal

Prognostic FactorsMedicineCancer ManagementThird-line ChemotherapyPathology +6